0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rabies Vaccine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-34M23
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rabies Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Rabies Vaccine Market Research Report 2024

Code: QYRE-Auto-34M23
Report
January 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rabies Vaccine Market Size

The global Rabies Vaccine market was valued at US$ 931 million in 2023 and is anticipated to reach US$ 1229.1 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.

Rabies Vaccine Market

Rabies Vaccine Market

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.

Report Scope

The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rabies Vaccine Market Report

Report Metric Details
Report Name Rabies Vaccine Market
Accounted market size in 2023 US$ 931 million
Forecasted market size in 2030 US$ 1229.1 million
CAGR 4.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Vero Cell Rabies Vaccine
  • BHK
  • Chick Embryo Cell Rabies Vaccine
  • Others
Segment by Application
  • Pre-exposure Prophylaxis
  • Post-exposure Prophylaxis
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Rabies Vaccine Market growing?

Ans: The Rabies Vaccine Market witnessing a CAGR of 4.0% during the forecast period 2024-2030.

What is the Rabies Vaccine Market size in 2030?

Ans: The Rabies Vaccine Market size in 2030 will be US$ 1229.1 million.

What is the market share of major companies in Rabies Vaccine Market?

Ans: Global top four manufacturers hold a share about 70%.

What is the Rabies Vaccine Market share by type?

Ans: In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%.

Who are the main players in the Rabies Vaccine Market report?

Ans: The main players in the Rabies Vaccine Market are GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen

What are the Application segmentation covered in the Rabies Vaccine Market report?

Ans: The Applications covered in the Rabies Vaccine Market report are Pre-exposure Prophylaxis, Post-exposure Prophylaxis

What are the Type segmentation covered in the Rabies Vaccine Market report?

Ans: The Types covered in the Rabies Vaccine Market report are Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Others

1 Rabies Vaccine Market Overview
1.1 Product Overview and Scope of Rabies Vaccine
1.2 Rabies Vaccine Segment by Type
1.2.1 Global Rabies Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Rabies Vaccine Segment by Application
1.3.1 Global Rabies Vaccine Market Value by Application: (2024-2030)
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Global Rabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Rabies Vaccine Revenue 2019-2030
1.4.2 Global Rabies Vaccine Sales 2019-2030
1.4.3 Global Rabies Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rabies Vaccine Market Competition by Manufacturers
2.1 Global Rabies Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rabies Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rabies Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Rabies Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rabies Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Vaccine, Product Type & Application
2.7 Rabies Vaccine Market Competitive Situation and Trends
2.7.1 Rabies Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rabies Vaccine Players Market Share by Revenue
2.7.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rabies Vaccine Retrospective Market Scenario by Region
3.1 Global Rabies Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rabies Vaccine Global Rabies Vaccine Sales by Region: 2019-2030
3.2.1 Global Rabies Vaccine Sales by Region: 2019-2024
3.2.2 Global Rabies Vaccine Sales by Region: 2025-2030
3.3 Global Rabies Vaccine Global Rabies Vaccine Revenue by Region: 2019-2030
3.3.1 Global Rabies Vaccine Revenue by Region: 2019-2024
3.3.2 Global Rabies Vaccine Revenue by Region: 2025-2030
3.4 North America Rabies Vaccine Market Facts & Figures by Country
3.4.1 North America Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rabies Vaccine Sales by Country (2019-2030)
3.4.3 North America Rabies Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rabies Vaccine Market Facts & Figures by Country
3.5.1 Europe Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rabies Vaccine Sales by Country (2019-2030)
3.5.3 Europe Rabies Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rabies Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Rabies Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rabies Vaccine Market Facts & Figures by Country
3.7.1 Latin America Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rabies Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Rabies Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rabies Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rabies Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rabies Vaccine Sales by Type (2019-2030)
4.1.1 Global Rabies Vaccine Sales by Type (2019-2024)
4.1.2 Global Rabies Vaccine Sales by Type (2025-2030)
4.1.3 Global Rabies Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Rabies Vaccine Revenue by Type (2019-2030)
4.2.1 Global Rabies Vaccine Revenue by Type (2019-2024)
4.2.2 Global Rabies Vaccine Revenue by Type (2025-2030)
4.2.3 Global Rabies Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Rabies Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rabies Vaccine Sales by Application (2019-2030)
5.1.1 Global Rabies Vaccine Sales by Application (2019-2024)
5.1.2 Global Rabies Vaccine Sales by Application (2025-2030)
5.1.3 Global Rabies Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Rabies Vaccine Revenue by Application (2019-2030)
5.2.1 Global Rabies Vaccine Revenue by Application (2019-2024)
5.2.2 Global Rabies Vaccine Revenue by Application (2025-2030)
5.2.3 Global Rabies Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Rabies Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK (Novartis)
6.1.1 GSK (Novartis) Corporation Information
6.1.2 GSK (Novartis) Description and Business Overview
6.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
6.1.5 GSK (Novartis) Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Chengda
6.3.1 Chengda Corporation Information
6.3.2 Chengda Description and Business Overview
6.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengda Rabies Vaccine Product Portfolio
6.3.5 Chengda Recent Developments/Updates
6.4 Yisheng
6.4.1 Yisheng Corporation Information
6.4.2 Yisheng Description and Business Overview
6.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yisheng Rabies Vaccine Product Portfolio
6.4.5 Yisheng Recent Developments/Updates
6.5 Prcmise
6.5.1 Prcmise Corporation Information
6.5.2 Prcmise Description and Business Overview
6.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Prcmise Rabies Vaccine Product Portfolio
6.5.5 Prcmise Recent Developments/Updates
6.6 VACN
6.6.1 VACN Corporation Information
6.6.2 VACN Description and Business Overview
6.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 VACN Rabies Vaccine Product Portfolio
6.6.5 VACN Recent Developments/Updates
6.7 Changsheng
6.6.1 Changsheng Corporation Information
6.6.2 Changsheng Description and Business Overview
6.6.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changsheng Rabies Vaccine Product Portfolio
6.7.5 Changsheng Recent Developments/Updates
6.8 BCHT
6.8.1 BCHT Corporation Information
6.8.2 BCHT Description and Business Overview
6.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BCHT Rabies Vaccine Product Portfolio
6.8.5 BCHT Recent Developments/Updates
6.9 Hissen
6.9.1 Hissen Corporation Information
6.9.2 Hissen Description and Business Overview
6.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hissen Rabies Vaccine Product Portfolio
6.9.5 Hissen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rabies Vaccine Industry Chain Analysis
7.2 Rabies Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Vaccine Production Mode & Process
7.4 Rabies Vaccine Sales and Marketing
7.4.1 Rabies Vaccine Sales Channels
7.4.2 Rabies Vaccine Distributors
7.5 Rabies Vaccine Customers
8 Rabies Vaccine Market Dynamics
8.1 Rabies Vaccine Industry Trends
8.2 Rabies Vaccine Market Drivers
8.3 Rabies Vaccine Market Challenges
8.4 Rabies Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Rabies Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Rabies Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Rabies Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Rabies Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Rabies Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Rabies Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Rabies Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Rabies Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Rabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Rabies Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Rabies Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Rabies Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Rabies Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Rabies Vaccine Sales by Region (2019-2024) & (K Units)
    Table 18. Global Rabies Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Rabies Vaccine Sales by Region (2025-2030) & (K Units)
    Table 20. Global Rabies Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Rabies Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Rabies Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Rabies Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Rabies Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Rabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Rabies Vaccine Sales by Country (2019-2024) & (K Units)
    Table 27. North America Rabies Vaccine Sales by Country (2025-2030) & (K Units)
    Table 28. North America Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Rabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Rabies Vaccine Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Rabies Vaccine Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Rabies Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Rabies Vaccine Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Rabies Vaccine Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Rabies Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Rabies Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Rabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Rabies Vaccine Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Rabies Vaccine Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Rabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Rabies Vaccine Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Rabies Vaccine Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Rabies Vaccine Sales (K Units) by Type (2019-2024)
    Table 51. Global Rabies Vaccine Sales (K Units) by Type (2025-2030)
    Table 52. Global Rabies Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Rabies Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Rabies Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Rabies Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Rabies Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Rabies Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Rabies Vaccine Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Rabies Vaccine Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Rabies Vaccine Sales (K Units) by Application (2019-2024)
    Table 61. Global Rabies Vaccine Sales (K Units) by Application (2025-2030)
    Table 62. Global Rabies Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Rabies Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Rabies Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Rabies Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Rabies Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Rabies Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Rabies Vaccine Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Rabies Vaccine Price (USD/Unit) by Application (2025-2030)
    Table 70. GSK (Novartis) Corporation Information
    Table 71. GSK (Novartis) Description and Business Overview
    Table 72. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. GSK (Novartis) Rabies Vaccine Product
    Table 74. GSK (Novartis) Recent Developments/Updates
    Table 75. Sanofi-Pasteur Corporation Information
    Table 76. Sanofi-Pasteur Description and Business Overview
    Table 77. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Sanofi-Pasteur Rabies Vaccine Product
    Table 79. Sanofi-Pasteur Recent Developments/Updates
    Table 80. Chengda Corporation Information
    Table 81. Chengda Description and Business Overview
    Table 82. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Chengda Rabies Vaccine Product
    Table 84. Chengda Recent Developments/Updates
    Table 85. Yisheng Corporation Information
    Table 86. Yisheng Description and Business Overview
    Table 87. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Yisheng Rabies Vaccine Product
    Table 89. Yisheng Recent Developments/Updates
    Table 90. Prcmise Corporation Information
    Table 91. Prcmise Description and Business Overview
    Table 92. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Prcmise Rabies Vaccine Product
    Table 94. Prcmise Recent Developments/Updates
    Table 95. VACN Corporation Information
    Table 96. VACN Description and Business Overview
    Table 97. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. VACN Rabies Vaccine Product
    Table 99. VACN Recent Developments/Updates
    Table 100. Changsheng Corporation Information
    Table 101. Changsheng Description and Business Overview
    Table 102. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Changsheng Rabies Vaccine Product
    Table 104. Changsheng Recent Developments/Updates
    Table 105. BCHT Corporation Information
    Table 106. BCHT Description and Business Overview
    Table 107. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. BCHT Rabies Vaccine Product
    Table 109. BCHT Recent Developments/Updates
    Table 110. Hissen Corporation Information
    Table 111. Hissen Description and Business Overview
    Table 112. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Hissen Rabies Vaccine Product
    Table 114. Hissen Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Rabies Vaccine Distributors List
    Table 118. Rabies Vaccine Customers List
    Table 119. Rabies Vaccine Market Trends
    Table 120. Rabies Vaccine Market Drivers
    Table 121. Rabies Vaccine Market Challenges
    Table 122. Rabies Vaccine Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Rabies Vaccine
    Figure 2. Global Rabies Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Rabies Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Vero Cell Rabies Vaccine Product Picture
    Figure 5. BHK Product Picture
    Figure 6. Chick Embryo Cell Rabies Vaccine Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Rabies Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Rabies Vaccine Market Share by Application in 2023 & 2030
    Figure 10. Pre-exposure Prophylaxis
    Figure 11. Post-exposure Prophylaxis
    Figure 12. Global Rabies Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Rabies Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Rabies Vaccine Sales (2019-2030) & (K Units)
    Figure 15. Global Rabies Vaccine Average Price (USD/Unit) & (2019-2030)
    Figure 16. Rabies Vaccine Report Years Considered
    Figure 17. Rabies Vaccine Sales Share by Manufacturers in 2023
    Figure 18. Global Rabies Vaccine Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Rabies Vaccine Players: Market Share by Revenue in 2023
    Figure 20. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Rabies Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Rabies Vaccine Sales Market Share by Country (2019-2030)
    Figure 23. North America Rabies Vaccine Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Rabies Vaccine Sales Market Share by Country (2019-2030)
    Figure 27. Europe Rabies Vaccine Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Rabies Vaccine Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Rabies Vaccine Revenue Market Share by Region (2019-2030)
    Figure 35. China Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Rabies Vaccine Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Rabies Vaccine Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Rabies Vaccine Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Rabies Vaccine Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Rabies Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Rabies Vaccine by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Rabies Vaccine by Type (2019-2030)
    Figure 56. Global Rabies Vaccine Price (USD/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Rabies Vaccine by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Rabies Vaccine by Application (2019-2030)
    Figure 59. Global Rabies Vaccine Price (USD/Unit) by Application (2019-2030)
    Figure 60. Rabies Vaccine Value Chain
    Figure 61. Rabies Vaccine Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS